Fritextsökning
Innehållstyper
-
Bio-Linux goes global
Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Virusforskare får Scilifelabpris
Forskningsinstitutet delar i samarbete med tidskriften Science ut pris till unga forskare.
-
Fokus på finansiering och IMI 2.0
Med IMI 2.0 i antågande diskuterade en internationell panel på investerarmässan Bioequity frågan om hur EU-finansiering och riskkapital kan göra Europa konkurre...
-
Prisar politiker och Lundaforskare
Riksdagsledamoten Barbro Westerholm och professorn Catharina Svanborg får pris från Forska Sverige.
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
Biovitrum sells UK part
Biovitrum will soon spin-out a British subsidary
-
Pfizer buys Swiss vaccines
Pfizer executes commercial license agreements for novel human vaccines based on the Swiss company Cytos Biotechnology's Immunodrug technology.
-
KI mörkade kritik
- ledningen påverkade oberoende experters utvärdering.
-
Life Science-branschen krymper
Krympande FoU-organisationer, färre småbolag och ökat utländskt ägande är några av de trender som presenteras i Vinnovas nya branschrapport som släpps i dag.
-
Discovery of new role for leukemia gene
Martin Bergö and his colleagues have studied two gene variants that often occur in acute leukemias. One gene codes for the protein RAS, which accelerates cell d...
-
Pronova Biopharma grows
Recently, Norway's Pronova Biopharma announced the creation of new jobs in Denmark
-
Danisco strengthens its IP team
Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.
-
A smart company takes care of its best
Lundbeck didn't have to look far to find it's new international Director of Marketing. The talent was already in the house.
-
Index Pharmaceuticals i jätteaffär
UPPDATERAD: Tecknar mångmiljonavtal med Almirall för Kappaproct och planerar börsnotering.
-
New Nordic biotech company
The Swiss biotech company Tillots Pharma opens a office in Stockholm, which will be run under private management.
-
Abbott expands by acquisition
An acquisition gives Abbott a leadership position in another large and growing medical device segment.
-
Nio etablerade forskare får EU-anslag
Passagereglering i blod-hjärnbarriären, riskfaktorer kring cancer och proteomanalyser är några forskningsområden som får anslag från Advanced Grant-programmet.
-
Follicum tar in pengar
Vill ha 38,5 miljoner inför kliniska studier med sitt håravfallspreparat.
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
Future drugs from Amaryllis
A Danish research team has discovered possibolities to extract drugs fro Amaryllis.
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Patent inte alltid rätt väg
Varje år skickar svenska universitetsforskare in hundratals patentansökningar, varav en stor del inom life science. Men det är långt ifrån alla upptäckter som t...
-
C-Rad till Stockholmsbörsen och tingsrätten
Tar klivet ut på Stockholmsbörsen och skyddar patent i tvist mot Baemocular.
BREAKING